OMGA logo

OMGA Omega Therapeutics, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$0.14
+0.00 (+0.00%)

Omega Therapeutics, Inc. functions as a biopharmaceutical firm in its development phase. Its innovative OMEGA Epigenomic Programming platform leverages epigenetics—nature's fundamental system for gene regulation and cell differentiation—to engineer therapeutic solutions. The company is advancing various omega epigenomic controller (OEC) candidates to tackle a spectrum of diseases. These candidates…

Market Cap: $7.90Mwww.omegatherapeutics.com

Price

No data yet.

Social Signal Score

50
5d
51
1 mentions
30d
50
2 mentions
60d
50
2 mentions
90d
50
2 mentions
news: 2

Analyst Ratings

7 analysts
Buyconsensus
Strong Buy 0Buy 6Hold 1Sell 0Strong Sell 0
Avg price target$9+6211.4%
Low $7Median $9High $11
Current Consensus

Revenue

$2.61M
$0.00$870.7K$1.74M$2.61M
Mar 2020Sep 2024

Analyst Estimates

FY2025
$-1.18
$-1.48$-0.75
2 analysts
FY2026
$-0.44
$-0.44$-0.44
1 analysts
FY2027
$-0.28
$-0.28$-0.28
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Kaan Certel
Sector
Healthcare
Industry
Biotechnology
Employees
93
Beta
1.64
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-4.95
www.omegatherapeutics.com